The Effect Of Risk Factors Considered Together With Preterm Birth History on Development

Sponsor
Gazi University (Other)
Overall Status
Completed
CT.gov ID
NCT05087511
Collaborator
(none)
48
1
11
4.4

Study Details

Study Description

Brief Summary

This thesis was planned to examine the effects of risk factors seen with a history of preterm birth on sensory and motor development in preschool children. A total of 48 children, 24 with only a history of preterm birth and 24 with additional risk factors for preterm birth, were included in the study.

Condition or Disease Intervention/Treatment Phase
  • Other: motor and sensory development assessment

Detailed Description

This thesis was planned to examine the effects of risk factors seen with a history of preterm birth on sensory and motor development in preschool children. A total of 48 children, 24 with only a history of preterm birth and 24 with additional risk factors for preterm birth, were included in the study. Additional risk factors, including respiratory distress syndrome, intraventricular bleeding, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity, and bronchopulmonary dysplasia, which are common in preterm infants, were recorded. Peabody Motor Development Scale-2 was used to evaluate motor development performances and Dunn Sensory Profile was used to evaluate sensory processing.

Study Design

Study Type:
Observational
Actual Enrollment :
48 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
The Effect Of Risk Factors Considered Together With Preterm Birth History On Sensory and Motor Development in Preschool Children
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Jun 30, 2021
Actual Study Completion Date :
Aug 31, 2021

Arms and Interventions

Arm Intervention/Treatment
only preterm birth

Peabody Motor Development Scale-2 was used to evaluate motor development performances and Dunn Sensory Profile was used to evaluate sensory processing

Other: motor and sensory development assessment
Peabody Motor Development Scale 2 was used to evaluate motor development and Dunn's Sensory Profile was used to evaluate sensory processing.

riskly preterm birth

Peabody Motor Development Scale-2 was used to evaluate motor development performances and Dunn Sensory Profile was used to evaluate sensory processing

Other: motor and sensory development assessment
Peabody Motor Development Scale 2 was used to evaluate motor development and Dunn's Sensory Profile was used to evaluate sensory processing.

Outcome Measures

Primary Outcome Measures

  1. Motor development [0-72 months]

    Peabody Motor Development Scale-2 was first developed in 1983 by Rhonda Folio and Rebecca Fewell. A second edition was published by the same authors in 2000. Offering separate tests and rating scales for both gross and fine motor skills, it is a frequently preferred tool for assessing the motor development of young children from birth to 72 months. The duration of the test is 45-60 minutes. Gross and fine motor assessments can be done on the same day or at different times. It is important to know the age of the child before starting the assessment and corrected age up to 2 years of age is used in preterm children. Each item is evaluated according to a 3-point (0,1,2) scoring scale. The therapist asks the child to do a certain item and observes how the child does the activity. Items are scored as 2, 1, or 0. Higher scores perform better.

  2. Sensory development [3-10 years]

    The Dunn sensory profile is a questionnaire filled out by a parent or primary caregiver that assesses children's reactions to events and sensory situations they encounter in daily life. The Dunn Sensory profile is suitable for assessing sensory development in children aged 3-10 years. The questionnaire consists of 125 items and the parent evaluates the event defined in each item according to the child's situation. For each of the 125 items, the parent was asked to respond on a five-point Likert scale of 1 = always, 2 = often, 3 = sometimes, 4 = rarely, and 5 = never. Higher scores perform better.

Secondary Outcome Measures

  1. Sensory development [7-36 month]

    Infant/toddler sensory profile (Dunn sensory profile 7-36) is a parent or caregiver questionnaire that evaluates the responses of children up to 3 years of age to sensory inputs. It was revised and updated as Dunn sensory profile II in 2014. BYDP has forms that evaluate two different age groups, 0-6 months and 7-36 months. It has items in six different sections: general, visual, auditory, vestibular, tactile, and oral. Parents evaluate their child's response to sensory stimuli on a 5-point Likert scale. 'Almost never' five; 'almost always' is rated as one. A higher score indicates that the behavior is observed less frequently. In addition to the total score, the items of the test provide score formation in four quadrants: low registration, sensory sensitivity, sensory avoidance, and sensory seeking.

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Months to 60 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Born before 37 weeks

  2. Not having a neurological diagnosis

  3. To be 24-60 months old,

  4. To be at a mental level to be able to understand and apply commands

Exclusion Criteria:
  1. Patients with diagnosed neurological, neuromuscular, genetic disease

  2. Children whose parents were not willing to participate in the study were not included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gazi University Ankara Yenimahalle Turkey

Sponsors and Collaborators

  • Gazi University

Investigators

  • Principal Investigator: rabia eraslan, Gazi University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Rabia Eraslan, principal investigator, Gazi University
ClinicalTrials.gov Identifier:
NCT05087511
Other Study ID Numbers:
  • Development in preterm birth
First Posted:
Oct 21, 2021
Last Update Posted:
Oct 21, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rabia Eraslan, principal investigator, Gazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 21, 2021